Low venous thromboembolic risk with bortezomib in multiple myeloma and potential protective effect with thalidomide/lenalidomide-based therapy: review of data from phase 3 trials and studies of novel combination regimens
(Q33901870)
scientific article
scientific article
Language:
| (P31) |
(Q13442814)
|
||||||||||||||||
| (P50) |
(Q56440981)
(Q66381375)
|
||||||||||||||||
| (P304) |
228-236
|
||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||
| (P433) |
2
|
||||||||||||||||
| (P478) |
11
|
||||||||||||||||
| (P577) |
Friday, April 8, 2011
|
||||||||||||||||
| (P921) |
(Q42824827)
(Q203174) (Q9397786)
(Q467635)
|
||||||||||||||||
| (P1433) |
(Q5133774)
|
||||||||||||||||
| (P1476) |
"Low venous thromboembolic risk with bortezomib in multiple myeloma and potential protective effect with thalidomide/lenalidomide-based therapy: review of data from phase 3 trials and studies of novel combination regimens" (language: en)
|
||||||||||||||||
| (P2093) |
Louis Fink
Guido Tricot
|
||||||||||||||||
| (P13046) |
(Q7318358)
|
other details